A phase II trial in patients with acute promyelocytic leukaemia (APML) to evaluate the effects of: all-trans retinoic acid (ATRA) combined with intensive idarubicin during induction and consolidation; subsequent intermittent all-trans retinoic acid; and molecular monitoring for evidence of minimal residual leukaemia and for evidence of incipient relapse, as measured by remission rate, relapse rate and overall survival. (APML03)

Dataset includes: Data for 107 patients with newly diagnosed APL Treatment involved use of all-trans retinoic acid (ATRA) combined with idarubicin Demographic data Diagnostic data Treatment data Outcome data

本数据集涵盖以下内容：107例初诊急性早幼粒细胞白血病（acute promyelocytic leukemia，APL）患者的相关数据；入组患者均采用全反式维甲酸（all-trans retinoic acid，ATRA）联合伊达比星（idarubicin）的治疗方案；数据集具体包含人口统计学资料、诊断资料、治疗相关资料及结局资料。